ABO-106
N/A
Report date: 2022/12/31 21:25:53
Base Information
Drug NameABO-106
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAbogen Biosciences Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAbogen Biosciences Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A